Skip to content

Application of indwelling needle modified puncture method in venipuncture of spastic limbs in patients

Application of indwelling needle modified puncture method in venipuncture of spastic limbs in patients with spinal cord injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127129
Enrollment
Unknown
Registered
2026-06-25
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Group A (Experimental Group):Improved puncture method for indwelling needles
Group B (Control Group):Improved puncture method for indwelling needles

Sponsors

Beijing Bo'ai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-75 years old; 2. Patients with clear diagnosis of cervical spinal cord injury who meet the relevant diagnostic criteria in Neurology (7th Edition); 3. The score of the patient's upper limbs is >= Grade 1 according to the Modified Ashworth Spasticity Scale for upper limbs; 4. Superficial vein graded as Grade III vessel 5. Venous transfusion is prescribed by the doctor due to the need of disease treatment; 6. The patient or his/her family members are informed of the research and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who have already had other infusion devices implanted; 2. Patients with skin infections, damage, edema, severe scars or other conditions that are not suitable for indwelling needle infusion therapy; 3. Patients who cannot cooperate due to cognitive impairment, disturbance of consciousness or other reasons; 4. Patients with venous thrombosis in the punctured limb shown by limb color Doppler ultrasound examination; 5. Complicated with severe coagulation disorders (e.g., INR > 1.5 or platelets < 50×10?/L); 6. Patients whose infused drugs are high-risk drugs such as chemotherapeutic drugs or hypertonic drugs; 7. Patients whose estimated infusion duration is less than 3 days; 8. Patients participating in other clinical trials that may interfere with the results of this study.

Design outcomes

Primary

MeasureTime frame
First-Attempt puncture success rate;

Secondary

MeasureTime frame
Incidence of redness and swelling at the puncture site;Incidence of bleeding at the puncture site;Natural indwelling duration;

Countries

China

Contacts

Public ContactSong Jie

Beijing Bo'ai Hospital

871941102@qq.com+86 10 8756 7548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026